Immediate Impact
4 by Nobel laureates 60 standout
Citing Papers
Resistance mechanisms to immune checkpoint inhibitors: updated insights
2025 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Works of Wei Lin being referenced
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
2019 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Wei Lin | 620 | 656 | 657 | 1096 | 838 | 148 | 3.0k | |
| Sang-Ho Cho | 521 | 263 | 214 | 263 | 458 | 135 | 2.3k | |
| Yanyu Zhang | 566 | 828 | 381 | 384 | 242 | 134 | 3.2k | |
| Hajime Yamaguchi | 893 | 258 | 458 | 132 | 482 | 172 | 3.5k | |
| Tengfei Zhang | 129 | 351 | 619 | 167 | 1252 | 249 | 4.2k | |
| Tatsuo Tanaka | 118 | 92 | 403 | 462 | 257 | 236 | 3.9k | |
| Wei Li | 763 | 260 | 1102 | 283 | 270 | 346 | 5.0k | |
| Marko Hočevar | 308 | 78 | 395 | 424 | 285 | 177 | 3.0k | |
| Jianmin Yang | 196 | 1113 | 255 | 191 | 393 | 269 | 4.8k | |
| Yifan Zhang | 249 | 379 | 74 | 328 | 183 | 126 | 2.0k | |
| Toshiaki Setoguchi | 319 | 1790 | 574 | 398 | 120 | 417 | 5.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...